Top Markets
Coin of the day
Canntab Therapeutics Limited Canntab Therapeutics Limited

Canntab Therapeutics Limited

PILL
Classificação em ações #40577
Canntab Therapeutics Limited, a phytopharmaceutical firm with its main office... Canntab Therapeutics Limited, a phytopharmaceutical firm with its main office in Markham, Canada, is dedicated to the research and development of sophisticated, medical-grade cannabinoid compounds. The company's diverse portfolio within Canada includes various orally administered pharmaceutical cannabis products. These innovative dosage forms encompass extended-release cannabinoid pellets, rapid-onset cannabidiol options, multi-layered modified-release formulations, quickly dissolving flash-melt versions, and dual-layer cannabinoid tablets. Canntab's products are designed to address a wide spectrum of health concerns, such as sleep disturbances, post-traumatic stress disorder, social anxiety, different forms of addiction, arthritic conditions, general pain management, alleviating pain and stimulating appetite for cancer patients, and aiding in recovery from opioid and other painkiller dependencies.
Preço da ação
$0.0036163
Última sincronização: 2023-10-30
Valor de mercado
$118.21K
Variação (1 dia)
0.39%
Variação (1 ano)
0.00%
País
CA
Negociar Canntab Therapeutics Limited (PILL)

Categoria

EPS de Canntab Therapeutics Limited (PILL)
EPS em 2026 TTM: 0
De acordo com os últimos relatórios financeiros e o preço das ações da Canntab Therapeutics Limited, o EPS atual da empresa (TTM) é 0. No final de 2026, a empresa teve um EPS de 0, igual a ao EPS de 2026, que foi de 0.
Histórico de EPS da Canntab Therapeutics Limited de 2026 até 2026
EPS no final de cada ano
Ano EPS Alterar
Não há dados suficientes para as datas fornecidas.
EPS de empresas semelhantes ou concorrentes